Shanghai Haini Pharmaceutical Co., Ltd., a key subsidiary of Yangtze River Pharmaceutical Group, is a modern pharmaceutical enterprise integrating R&D, production and marketing, located in Pudong New Area, Shanghai.Adhering to strict international GMP standards, the company operates a number of advanced pharmaceutical production lines covering cardiovascular, digestive, gynecological, anti-infective and other therapeutic fields. It owns well-known brands such as Landi, Tianli and Xuesu, enjoying wide recognition and reputation in the domestic market.Driven by innovation, the company leverages the Group's R&D platform and Shanghai's scientific and technological resources to continuously conduct generic drug consistency evaluation and new drug development. It has been successively honored as a National Green Factory and a National Green Supply Chain Enterprise.While deeply rooted in the domestic market, Shanghai Haini Pharmaceutical actively expands its international business. It promotes product registration and certification in line with ICH, FDA, EMA and other international standards, steadily developing global markets including Europe, America, Southeast Asia, the Middle East and Africa. The company carries out pharmaceutical exports, international certification applications and overseas cooperation.Looking ahead, it will continue to enhance global competitiveness, bring high-quality pharmaceutical products to the world, and provide safe and effective medical solutions for patients worldwide.